New Amgen Drug MariTide Shows Promising Weight Loss in Early Data

New Amgen Drug MariTide Shows Promising Weight Loss in Early Data

The New York Times - Business:

The drug, which is named MariTide and delivered in a monthly injection, is years from being sold, but caused an average of up to 20 percent weight loss in a small group of patients.

This post first appeared in The New York Times - Business. Read the original article.

Leave a Comment

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *